SynGap Missense Server

Table of SynGAP1 Isoform α2 (UniProt Q96PV0-1) Missense Variants.

c.dna Variant SGM Consensus Domain ClinVar gnomAD ESM1b AlphaMissense REVEL FoldX Rosetta Foldetta PremPS PROVEAN PolyPhen-2 HumDiv PolyPhen-2 HumVar FATHMM SIFT PAM Physical SASA Normalized B-factor backbone Normalized B-factor sidechain SynGAP Structural Annotation DOI
Clinical Status Review Subm. ID Allele count Allele freq. LLR score Prediction Pathogenicity Class Optimized Score Prediction Average ΔΔG Prediction StdDev ΔΔG Prediction ΔΔG Prediction ΔΔG Prediction Score Prediction pph2_prob Prediction pph2_prob Prediction Nervous System Score Prediction Prediction Status Conservation Sequences PAM250 PAM120 Hydropathy Δ MW Δ Average Δ Δ StdDev Δ StdDev Secondary Tertiary bonds Inside out GAP-Ras interface At membrane No effect MD Alert Verdict Description
c.3209_3210delinsCAR1070TLikely BenignUncertain 1-5.093Likely Benign0.860Likely PathogenicAmbiguous-2.35Neutral0.948Possibly Damaging0.507Possibly Damaging3.78Benign0.01Affected3.775-1-13.8-55.08
c.2635_2636delinsAAA879KLikely BenignLikely Benign 1-5.877Likely Benign0.757Likely PathogenicLikely Benign-0.71Neutral0.969Probably Damaging0.593Possibly Damaging2.69Benign0.21Tolerated3.775-1-1-5.757.10
c.3511_3512delinsTGA1171CLikely BenignCoiled-coilUncertain 1-5.363Likely Benign0.496AmbiguousLikely Benign-1.16Neutral0.978Probably Damaging0.825Possibly Damaging5.32Benign0.02Affected4.324-200.732.06
c.2699C>TT900MLikely BenignConflicting 26-33443251-C-T148.68e-6-3.852Likely Benign0.176Likely BenignLikely Benign0.015Likely Benign-0.81Neutral0.060Benign0.016Benign2.79Benign0.08Tolerated4.324-1-12.630.09
c.3048C>AD1016ELikely BenignLikely Benign 16-33443600-C-A21.24e-6-3.422Likely Benign0.216Likely BenignLikely Benign0.017Likely Benign-0.37Neutral0.008Benign0.028Benign2.64Benign0.65Tolerated3.775230.014.03
c.103G>AV35ILikely BenignUncertain 16-33423512-G-A53.10e-6-3.764Likely Benign0.081Likely BenignLikely Benign0.017Likely Benign-0.32Neutral0.672Possibly Damaging0.369Benign4.16Benign0.00Affected4.321340.314.03
c.2408A>GK803RLikely BenignSH3-binding motifUncertain 1-2.281Likely Benign0.097Likely BenignLikely Benign0.018Likely Benign-1.52Neutral0.103Benign0.038Benign2.38Pathogenic0.00Affected3.77532-0.628.01
c.1027G>AV343I
(3D Viewer)
Likely BenignC2Uncertain 26-33437932-G-A16.20e-7-6.020Likely Benign0.117Likely BenignLikely Benign0.020Likely Benign-0.27Likely Benign0.0-0.04Likely Benign-0.16Likely Benign-0.39Likely Benign-0.14Neutral0.159Benign0.084Benign1.98Pathogenic0.27Tolerated3.3725430.314.03240.2-26.9-0.20.2-0.20.2XPotentially BenignThe iso-propyl side chain of Val343, located in an anti-parallel β sheet strand (res. Gly341-Pro349), is packing against multiple hydrophobic residues of the C2 domain (e.g., Leu327, Leu274, Val365). In the variant simulations, the sec-butyl side chain of Ile343 is basically able to form the same interactions as valine due to its similar hydrophobic profile. The residue swap also does not seem to cause negative effects on the protein structure based on the simulations.
c.1312G>AA438T
(3D Viewer)
Likely BenignGAPConflicting 36-33438217-G-A169.91e-6-5.339Likely Benign0.085Likely BenignLikely Benign0.021Likely Benign0.21Likely Benign0.0-0.07Likely Benign0.07Likely Benign0.36Likely Benign-0.81Neutral0.300Benign0.011Benign4.18Benign0.14Tolerated3.382610-2.530.03214.2-42.7-0.30.1-0.40.1XPotentially BenignThe methyl group of Ala438, located in a four-residue loop connecting two α helices (res. Asn440-Thr458 and Pro413-Glu436), packs against hydrophobic residues from a nearby α helix or loop residues (e.g., Leu703, Val699). In the variant simulations, the methyl group of Thr438 is able to establish similar hydrophobic packing. Moreover, the hydroxyl group also H-bonds with nearby residues, such as the carbonyl group of the neighboring loop residue Pro437. Accordingly, the residue swap does not generate an apparent negative effect on the protein structure based on the simulations.
c.106C>TH36YLikely BenignUncertain 16-33423515-C-T21.24e-6-3.461Likely Benign0.139Likely BenignLikely Benign0.023Likely Benign-1.03Neutral0.219Benign0.066Benign4.16Benign0.00Affected4.321021.926.03
c.3134C>GA1045GLikely BenignBenign/Likely benign 76-33443686-C-G14078.72e-4-3.246Likely Benign0.075Likely BenignLikely Benign0.024Likely Benign-1.21Neutral0.224Benign0.066Benign2.64Benign0.33Tolerated3.77510-2.2-14.0310.1016/j.ajhg.2020.11.011
c.597C>AN199K
(3D Viewer)
PHUncertain 1-8.198Likely Pathogenic0.686Likely PathogenicLikely Benign0.024Likely Benign-0.19Likely Benign0.10.03Likely Benign-0.08Likely Benign0.33Likely Benign-1.48Neutral0.276Benign0.083Benign4.27Benign0.13Tolerated3.47910-0.414.07207.821.5-0.11.50.10.0XUncertainAsn199, located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by a positively charged lysine. On the protein surface, both the carboxamide group of Asn199 and the amino group of Lys199 side chains can form hydrogen bonds with the backbone carbonyl groups of residues (e.g., Ala249) at the end of an α helix (res. Ala236-Lys251). However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.958G>AV320I
(3D Viewer)
Likely BenignC2Uncertain 1-5.220Likely Benign0.111Likely BenignLikely Benign0.027Likely Benign-0.27Likely Benign0.20.66Ambiguous0.20Likely Benign0.01Likely Benign-0.21Neutral0.198Benign0.114Benign1.77Pathogenic0.45Tolerated3.3823340.314.03
c.1055C>AT352N
(3D Viewer)
Likely BenignC2Likely Benign 16-33437960-C-A21.24e-6-4.817Likely Benign0.117Likely BenignLikely Benign0.027Likely Benign0.20Likely Benign0.0-0.04Likely Benign0.08Likely Benign0.45Likely Benign-0.92Neutral0.255Benign0.057Benign1.75Pathogenic0.19Tolerated3.372500-2.813.00208.4-14.5-0.20.1-0.10.0XPotentially BenignThr352 is located in a short α helical section within a loop connecting two β strands (res. Gly341-Pro349, res. Thr359-Pro364) originating from two different anti-parallel β sheets of the C2 domain. In the WT simulations, the side chain hydroxyl and backbone amide groups of Thr354 form hydrogen bonds with the backbone carbonyl group of Pro349 at the end of the preceding β strand. This arrangement likely stabilizes the α helical section and aids in folding, keeping the short secondary structure element intact in the variant simulations. However, the carboxamide group of the Asn352 side chain does not form hydrogen bonds with the backbone carbonyl group of Pro349. Instead, it packs against the cyclic ring and forms hydrogen bonds with the phenol group of the Tyr363 side chain in the other β strand.
c.3705G>AM1235ILikely BenignCoiled-coilUncertain 1-4.312Likely Benign0.310Likely BenignLikely Benign0.027Likely Benign-1.44Neutral0.139Benign0.056Benign2.69Benign0.04Affected3.775122.6-18.03
c.2690C>TS897LLikely BenignUncertain 1-4.034Likely Benign0.299Likely BenignLikely Benign0.028Likely Benign-1.71Neutral0.901Possibly Damaging0.636Possibly Damaging2.66Benign0.01Affected-3-24.626.08
c.2702C>TA901VLikely BenignUncertain 26-33443254-C-T21.24e-6-5.043Likely Benign0.219Likely BenignLikely Benign0.029Likely Benign-1.83Neutral0.106Benign0.009Benign2.64Benign0.17Tolerated3.775002.428.05
c.2207G>AR736HLikely BenignUncertain 16-33441672-G-A63.72e-6-5.409Likely Benign0.067Likely BenignLikely Benign0.029Likely Benign-0.12Neutral0.004Benign0.001Benign2.50Benign0.00Affected4.073201.3-19.05
c.2200C>TP734SLikely BenignUncertain 26-33441665-C-T21.24e-6-4.291Likely Benign0.077Likely BenignLikely Benign0.030Likely Benign-2.44Neutral0.344Benign0.048Benign2.77Benign0.11Tolerated3.6461-10.8-10.0410.1016/j.ajhg.2020.11.011
c.221G>AS74NLikely BenignUncertain 16-33425829-G-A53.10e-6-5.156Likely Benign0.112Likely BenignLikely Benign0.031Likely Benign-0.89Neutral0.043Benign0.007Benign4.09Benign0.00Affected4.32111-2.727.03
c.3328A>GS1110GLikely BenignLikely Benign 1-4.674Likely Benign0.079Likely BenignLikely Benign0.035Likely Benign-2.26Neutral0.036Benign0.026Benign2.19Pathogenic0.08Tolerated4.322100.4-30.03
c.3858A>TE1286DLikely BenignConflicting 46-33447906-A-T1439.22e-5-4.010Likely Benign0.081Likely BenignLikely Benign0.036Likely Benign1.02Neutral0.001Benign0.004Benign2.96Benign1.00Tolerated3.775320.0-14.0310.1016/j.ajhg.2020.11.011
c.380G>AR127QLikely BenignUncertain 16-33432245-G-A63.72e-6-1.711Likely Benign0.320Likely BenignLikely Benign0.037Likely Benign-1.04Neutral0.006Benign0.001Benign4.04Benign0.02Affected3.744111.0-28.06
c.74G>AR25QLikely BenignUncertain 16-33423483-G-A159.29e-6-4.126Likely Benign0.212Likely BenignLikely Benign0.038Likely Benign-0.70Neutral0.829Possibly Damaging0.614Possibly Damaging4.01Benign0.00Affected4.321111.0-28.06
c.2591C>TA864VLikely BenignUncertain 26-33443143-C-T63.72e-6-4.749Likely Benign0.126Likely BenignLikely Benign0.038Likely Benign-1.35Neutral0.767Possibly Damaging0.119Benign2.45Pathogenic0.30Tolerated3.824002.428.05
c.2401G>AG801SLikely BenignSH3-binding motifUncertain 1-3.665Likely Benign0.087Likely BenignLikely Benign0.039Likely Benign-0.41Neutral0.009Benign0.019Benign2.76Benign0.48Tolerated4.32201-0.430.03
c.2912C>AP971HLikely BenignUncertain 16-33443464-C-A16.20e-7-5.243Likely Benign0.086Likely BenignLikely Benign0.039Likely Benign-1.11Neutral0.898Possibly Damaging0.477Possibly Damaging3.89Benign0.00Affected4.322-20-1.640.02
c.2578G>AV860ILikely BenignBenign 16-33443130-G-A211.30e-5-4.516Likely Benign0.095Likely BenignLikely Benign0.039Likely Benign-0.42Neutral0.009Benign0.006Benign4.24Benign0.00Affected3.775430.314.03
c.2987C>GP996RLikely BenignBenign 1-4.457Likely Benign0.141Likely BenignLikely Benign0.040Likely Benign-1.04Neutral0.144Benign0.085Benign4.26Benign0.01Affected4.324-20-2.959.07
c.2567A>GN856SLikely BenignUncertain 16-33443119-A-G21.24e-6-2.104Likely Benign0.064Likely BenignLikely Benign0.040Likely Benign-1.54Neutral0.901Possibly Damaging0.535Possibly Damaging4.16Benign0.30Tolerated3.883112.7-27.03
c.2695A>GI899VLikely BenignBenign 16-33443247-A-G63.72e-6-2.569Likely Benign0.074Likely BenignLikely Benign0.040Likely Benign0.09Neutral0.220Benign0.078Benign2.75Benign0.92Tolerated4.32443-0.3-14.03
c.3574C>GL1192VLikely BenignCoiled-coilUncertain 1-4.132Likely Benign0.471AmbiguousLikely Benign0.041Likely Benign-0.89Neutral0.779Possibly Damaging0.527Possibly Damaging2.69Benign0.16Tolerated210.4-14.03
c.3136C>GP1046ALikely BenignUncertain 16-33443688-C-G16.20e-7-3.246Likely Benign0.048Likely BenignLikely Benign0.041Likely Benign-1.67Neutral0.001Benign0.008Benign2.39Pathogenic0.29Tolerated3.775-113.4-26.04
c.2711T>CM904TLikely BenignUncertain 1-2.721Likely Benign0.668Likely PathogenicLikely Benign0.042Likely Benign-1.15Neutral0.277Benign0.103Benign2.78Benign0.18Tolerated3.775-1-1-2.6-30.09
c.2983C>TP995SLikely BenignUncertain 1-4.457Likely Benign0.071Likely BenignLikely Benign0.042Likely Benign-1.03Neutral0.011Benign0.015Benign4.24Benign0.00Affected4.3211-10.8-10.04
c.2393C>TP798LLikely BenignSH3-binding motifUncertain 26-33442945-C-T63.72e-6-5.640Likely Benign0.074Likely BenignLikely Benign0.042Likely Benign-0.86Neutral0.981Probably Damaging0.631Possibly Damaging4.21Benign0.00Affected4.321-3-35.416.04
c.2349G>AM783ILikely BenignBenign 16-33442901-G-A63.72e-6-3.560Likely Benign0.418AmbiguousLikely Benign0.042Likely Benign-0.54Neutral0.004Benign0.006Benign2.87Benign0.22Tolerated3.646122.6-18.03
c.3983G>AR1328QLikely BenignUncertain 36-33451857-G-A351.49e-4-2.921Likely Benign0.273Likely BenignLikely Benign0.043Likely Benign-1.02Neutral0.799Possibly Damaging0.098Benign4.12Benign0.03Affected3.775111.0-28.06
c.3304G>AA1102TLikely BenignUncertain 16-33443856-G-A117.17e-6-3.540Likely Benign0.070Likely BenignLikely Benign0.044Likely Benign-0.30Neutral0.001Benign0.001Benign2.32Pathogenic0.95Tolerated3.77510-2.530.03
c.3859C>AP1287TLikely BenignUncertain 16-33447907-C-A-3.940Likely Benign0.077Likely BenignLikely Benign0.044Likely Benign-0.22Neutral0.126Benign0.041Benign2.78Benign0.04Affected3.775-100.93.99
c.2195G>AR732KLikely BenignConflicting 26-33441660-G-A42.48e-6-5.278Likely Benign0.240Likely BenignLikely Benign0.045Likely Benign-0.82Neutral0.973Probably Damaging0.943Probably Damaging2.69Benign0.21Tolerated3.597320.6-28.01
c.2168C>TT723I
(3D Viewer)
Likely BenignGAPLikely Benign 16-33441633-C-T21.24e-6-2.591Likely Benign0.120Likely BenignLikely Benign0.045Likely Benign-0.39Likely Benign0.0-0.20Likely Benign-0.30Likely Benign0.26Likely Benign-2.09Neutral0.088Benign0.030Benign3.39Benign0.03Affected3.5080-15.212.05252.3-31.60.00.0-0.20.2XUncertainThe hydroxyl group of Thr723, located on the outer surface of an α-helix (res. Leu714-Arg726), continuously forms hydrogen bonds with the backbone carbonyl of Asn719 in the WT simulations, potentially lowering the stability of the α-helix. In the variant simulations, the sec-butyl side chain of Ile723 cannot form any hydrogen bonds, which, in theory, could increase the helix stability. However, because the model ends abruptly at the C-terminus, no definite conclusions can be drawn based on the simulations.
c.2914C>GP972ALikely BenignUncertain 16-33443466-C-G16.20e-7-0.167Likely Benign0.045Likely BenignLikely Benign0.046Likely Benign-0.89Neutral0.016Benign0.011Benign4.29Benign0.07Tolerated4.322-113.4-26.04
c.2596G>TV866LLikely BenignUncertain 16-33443148-G-T16.20e-7-3.352Likely Benign0.148Likely BenignLikely Benign0.046Likely Benign-0.97Neutral0.217Benign0.229Benign2.71Benign0.21Tolerated3.82421-0.414.03
c.2014A>GT672A
(3D Viewer)
Likely BenignGAPBenign 16-33441273-A-G31.86e-6-6.524Likely Benign0.109Likely BenignLikely Benign0.046Likely Benign0.51Ambiguous0.31.15Ambiguous0.83Ambiguous0.65Ambiguous-3.20Deleterious0.006Benign0.002Benign3.44Benign0.12Tolerated3.4025102.5-30.03188.542.5-0.10.30.20.0XPotentially PathogenicThe hydroxyl group of Thr672, located in an entangled α-α loop connecting the two α-helices (res. Ser641-Glu666 and res. Leu685-Val699), is involved in a highly coordinated hydrogen-bonding network between residues from two α-helices (res. Ser641-Glu666 and res. Arg563-Glu578) and from the α-α loop itself, such as Lys566, Glu666, and Asn669. In the variant simulations, Ala672 can only form a hydrogen bond with Lys566 via its backbone carbonyl group. Consequently, it cannot maintain the Lys566-Glu666 salt bridge through hydrogen bonding, leading to a significant disruption of the intricate and stable hydrogen-bond network between the loop and the helices.
c.2350G>AA784TLikely BenignBenign 1-3.579Likely Benign0.089Likely BenignLikely Benign0.046Likely Benign1.23Neutral0.001Benign0.006Benign2.92Benign1.00Tolerated3.64610-2.530.03
c.3848C>TP1283LLikely BenignBenign 16-33447896-C-T322.06e-5-3.740Likely Benign0.093Likely BenignLikely Benign0.047Likely Benign-1.04Neutral0.005Benign0.003Benign2.76Benign0.06Tolerated3.775-3-35.416.04
c.2239G>CV747LLikely BenignUncertain 16-33441704-G-C21.24e-6-2.790Likely Benign0.096Likely BenignLikely Benign0.047Likely Benign-0.52Neutral0.065Benign0.033Benign2.67Benign0.00Affected4.32221-0.414.03
c.82T>CS28PLikely BenignUncertain 1-3.309Likely Benign0.051Likely BenignLikely Benign0.047Likely Benign1.37Neutral0.000Benign0.000Benign4.53Benign0.00Affected4.3211-1-0.810.04
c.2275A>CM759LLikely BenignUncertain 16-33441740-A-C21.24e-6-2.431Likely Benign0.093Likely BenignLikely Benign0.048Likely Benign-0.53Neutral0.002Benign0.005Benign2.84Benign1.00Tolerated3.995421.9-18.03
c.50C>TS17FLikely BenignUncertain 16-33420314-C-T106.49e-6-3.888Likely Benign0.637Likely PathogenicLikely Benign0.048Likely Benign-0.99Neutral0.486Possibly Damaging0.032Benign3.99Benign0.00Affected4.321-2-33.660.10
c.2302G>AD768NLikely BenignUncertain 16-33442460-G-A22.57e-6-6.892Likely Benign0.453AmbiguousLikely Benign0.048Likely Benign-0.77Neutral0.106Benign0.009Benign4.07Benign0.96Tolerated3.646120.0-0.98
c.2825C>TP942LLikely BenignUncertain 16-33443377-C-T42.48e-6-5.063Likely Benign0.086Likely BenignLikely Benign0.048Likely Benign-2.00Neutral0.411Benign0.239Benign2.37Pathogenic0.00Affected4.324-3-35.416.04
c.3961C>TP1321SLikely BenignUncertain 26-33451835-C-T106.46e-6-4.897Likely Benign0.077Likely BenignLikely Benign0.049Likely Benign0.68Neutral0.028Benign0.004Benign4.27Benign0.71Tolerated3.7751-10.8-10.0410.1016/j.ajhg.2020.11.011
c.3970C>TP1324SLikely BenignLikely Benign 16-33451844-C-T53.26e-6-5.451Likely Benign0.068Likely BenignLikely Benign0.049Likely Benign0.35Neutral0.225Benign0.092Benign4.33Benign0.00Affected4.3211-10.8-10.04
c.3941C>TP1314LLikely BenignLikely Benign 16-33451815-C-T21.24e-6-4.040Likely Benign0.118Likely BenignLikely Benign0.049Likely Benign-0.20Neutral0.421Benign0.066Benign4.19Benign0.05Affected3.775-3-35.416.04
c.2743G>AG915SLikely BenignBenign 16-33443295-G-A95.58e-6-3.557Likely Benign0.083Likely BenignLikely Benign0.050Likely Benign-0.88Neutral0.801Possibly Damaging0.201Benign2.73Benign0.31Tolerated3.77510-0.430.03
c.263T>CV88ALikely BenignUncertain 1-5.860Likely Benign0.993Likely PathogenicLikely Pathogenic0.050Likely Benign-1.22Neutral0.053Benign0.008Benign3.75Benign0.00Affected4.32100-2.4-28.05
c.169C>TL57FLikely BenignUncertain 2-5.096Likely Benign0.459AmbiguousLikely Benign0.051Likely Benign-0.78Neutral0.824Possibly Damaging0.879Possibly Damaging3.96Benign0.00Affected4.32120-1.034.02
c.92G>AR31QLikely BenignUncertain 16-33423501-G-A74.34e-6-4.434Likely Benign0.136Likely BenignLikely Benign0.051Likely Benign-0.92Neutral0.829Possibly Damaging0.614Possibly Damaging4.01Benign0.00Affected4.321111.0-28.06
c.3041G>TG1014VLikely BenignUncertain 1-4.612Likely Benign0.181Likely BenignLikely Benign0.053Likely Benign-2.47Neutral0.818Possibly Damaging0.377Benign2.72Benign0.06Tolerated3.775-1-34.642.08
c.1322T>CV441A
(3D Viewer)
GAPConflicting 26-33438227-T-C31.86e-6-9.439Likely Pathogenic0.359AmbiguousLikely Benign0.053Likely Benign-0.14Likely Benign0.00.33Likely Benign0.10Likely Benign0.95Ambiguous-2.92Deleterious0.513Possibly Damaging0.214Benign3.44Benign0.93Tolerated3.372900-2.4-28.05195.044.60.00.10.50.0XXUncertainThe iso-propyl side chain of Val441, located on the outer surface of an α helix (res. Asn440-Thr458), does not interact with other residues in the WT simulations. In the variant simulations, the methyl side chain of Ala441 is similarly hydrophobic and does not form any interactions on the outer helix surface. Although the residue swap does not negatively affect the protein structure based on the simulations, it is noteworthy that the residue faces the RasGTPase interface. Thus, the effect of the residue swap on the SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.2822C>TP941LLikely BenignUncertain 2-5.692Likely Benign0.066Likely BenignLikely Benign0.054Likely Benign-0.44Neutral0.144Benign0.039Benign2.76Benign0.01Affected-3-35.416.04
c.2225G>AR742QLikely BenignUncertain 26-33441690-G-A241.49e-5-4.090Likely Benign0.068Likely BenignLikely Benign0.054Likely Benign-0.19Neutral0.032Benign0.007Benign2.73Benign0.07Tolerated4.322111.0-28.06
c.3962C>AP1321QLikely BenignBenign 16-33451836-C-A16.58e-7-5.594Likely Benign0.079Likely BenignLikely Benign0.055Likely Benign-0.74Neutral0.659Possibly Damaging0.034Benign4.24Benign0.09Tolerated3.7750-1-1.931.01
c.2651G>AR884QLikely BenignUncertain 26-33443203-G-A53.10e-6-3.785Likely Benign0.128Likely BenignLikely Benign0.055Likely Benign-0.42Neutral0.012Benign0.004Benign2.62Benign0.36Tolerated4.324111.0-28.06
c.2502G>CM834ILikely BenignUncertain 1-3.377Likely Benign0.291Likely BenignLikely Benign0.055Likely Benign-1.21Neutral0.026Benign0.009Benign2.56Benign0.00Affected4.324122.6-18.03
c.2243T>GL748RLikely BenignConflicting 26-33441708-T-G31.86e-6-3.331Likely Benign0.245Likely BenignLikely Benign0.055Likely Benign-0.67Neutral0.912Possibly Damaging0.448Possibly Damaging2.73Benign0.02Affected4.322-3-2-8.343.03
c.2669G>AR890HLikely BenignBenign 16-33443221-G-A191.18e-5-3.600Likely Benign0.198Likely BenignLikely Benign0.056Likely Benign-1.29Neutral0.254Benign0.134Benign3.97Benign0.15Tolerated4.324201.3-19.05
c.127G>AG43SLikely BenignUncertain 26-33423536-G-A16.20e-7-3.301Likely Benign0.078Likely BenignLikely Benign0.057Likely Benign-0.30Neutral0.162Benign0.096Benign4.29Benign0.00Affected4.32110-0.430.03
c.48G>AM16ILikely BenignUncertain 16-33420312-G-A16.49e-7-2.198Likely Benign0.722Likely PathogenicLikely Benign0.057Likely Benign-0.15Neutral0.000Benign0.000Benign4.28Benign0.00Affected4.321212.6-18.03
c.2420A>TY807FLikely BenignSH3-binding motifUncertain 1-3.667Likely Benign0.073Likely BenignLikely Benign0.057Likely Benign0.14Neutral0.012Benign0.022Benign2.92Benign0.98Tolerated3.775734.1-16.00
c.2710A>GM904VLikely BenignLikely Benign 26-33443262-A-G774.78e-5-2.907Likely Benign0.112Likely BenignLikely Benign0.058Likely Benign-0.33Neutral0.039Benign0.023Benign2.80Benign0.10Tolerated3.775212.3-32.06
c.2111G>AS704N
(3D Viewer)
Likely BenignGAPBenign/Likely benign 36-33441370-G-A271.67e-5-5.917Likely Benign0.421AmbiguousLikely Benign0.058Likely Benign0.48Likely Benign0.1-0.12Likely Benign0.18Likely Benign0.54Ambiguous-0.49Neutral0.771Possibly Damaging0.275Benign3.39Benign0.08Tolerated3.471011-2.727.03233.2-29.1-0.10.0-0.10.1XPotentially BenignSer704 is located at the end and outer surface of an α-helix (res. Thr704-Gly712), which is connected via a tight turn or loop to another α-helix (res. Asp684-Gln702). The hydroxyl side chain of Ser704 occasionally forms a hydrogen bond with the amide group of Ala707. However, in the variant simulations, the carboxamide side chain of Asn704 achieves more lasting and numerous hydrogen-bonding interactions with the residues at the helix end, such as Glu706, Ala707, and Leu708. Consequently, the residue swap could strengthen the α-helix secondary structure integrity at the helix end, which could have either positive or negative effects on its function.
c.2291A>GN764SLikely BenignBenign 1-3.149Likely Benign0.159Likely BenignLikely Benign0.058Likely Benign-0.84Neutral0.992Probably Damaging0.846Possibly Damaging2.65Benign0.61Tolerated3.646112.7-27.03
c.3038C>GS1013CLikely BenignUncertain 16-33443590-C-G42.48e-6-6.745Likely Benign0.110Likely BenignLikely Benign0.058Likely Benign-2.06Neutral0.898Possibly Damaging0.579Possibly Damaging2.64Benign0.05Affected3.7750-13.316.06
c.1040C>AT347N
(3D Viewer)
Likely BenignC2Uncertain 16-33437945-C-A95.58e-6-5.545Likely Benign0.165Likely BenignLikely Benign0.059Likely Benign0.41Likely Benign0.10.46Likely Benign0.44Likely Benign-0.06Likely Benign1.96Neutral0.001Benign0.001Benign1.67Pathogenic0.60Tolerated3.372500-2.813.00
c.2596G>AV866ILikely BenignConflicting 36-33443148-G-A53.10e-6-4.652Likely Benign0.118Likely BenignLikely Benign0.059Likely Benign-0.39Neutral0.957Probably Damaging0.541Possibly Damaging2.69Benign0.27Tolerated3.824430.314.03
c.3100C>GP1034ALikely BenignBenign 1-4.174Likely Benign0.178Likely BenignLikely Benign0.060Likely Benign-2.44Neutral0.059Benign0.061Benign2.47Pathogenic0.06Tolerated3.7751-13.4-26.04
c.3983G>CR1328PLikely BenignBenign 16-33451857-G-C-1.220Likely Benign0.466AmbiguousLikely Benign0.060Likely Benign-2.01Neutral0.927Possibly Damaging0.452Possibly Damaging4.06Benign0.01Affected3.7750-22.9-59.07
c.2305C>TL769FLikely BenignUncertain 1-5.044Likely Benign0.146Likely BenignLikely Benign0.060Likely Benign-0.89Neutral0.925Possibly Damaging0.510Possibly Damaging3.94Benign0.02Affected20-1.034.02
c.2818G>CG940RLikely BenignBenign 16-33443370-G-C53.10e-6-6.169Likely Benign0.480AmbiguousLikely Benign0.060Likely Benign0.02Neutral0.922Possibly Damaging0.543Possibly Damaging2.73Benign0.15Tolerated3.775-3-2-4.199.14
c.3338G>AG1113DLikely BenignUncertain 16-33443890-G-A-4.638Likely Benign0.354AmbiguousLikely Benign0.061Likely Benign-0.72Neutral0.029Benign0.017Benign2.58Benign0.34Tolerated4.322-11-3.158.04
c.2657C>TA886VLikely BenignUncertain 16-33443209-C-T181.12e-5-4.478Likely Benign0.078Likely BenignLikely Benign0.061Likely Benign-0.20Neutral0.888Possibly Damaging0.314Benign2.17Pathogenic0.00Affected4.324002.428.05
c.3860C>TP1287LLikely BenignConflicting 26-33447908-C-T-2.800Likely Benign0.117Likely BenignLikely Benign0.061Likely Benign-1.66Neutral0.021Benign0.017Benign2.76Benign0.02Affected3.775-3-35.416.04
c.233G>TR78LLikely BenignUncertain 1-3.389Likely Benign0.635Likely PathogenicLikely Benign0.062Likely Benign-1.59Neutral0.385Benign0.021Benign3.84Benign0.00Affected-3-28.3-43.03
c.4008G>CE1336DLikely BenignLikely Benign 1-3.344Likely Benign0.596Likely PathogenicLikely Benign0.062Likely Benign-1.92Neutral0.001Benign0.003Benign3.30Benign0.00Affected3.775230.0-14.03
c.3293G>AS1098NLikely BenignConflicting 26-33443845-G-A63.89e-6-5.120Likely Benign0.156Likely BenignLikely Benign0.063Likely Benign-0.58Neutral0.369Benign0.120Benign2.76Benign0.36Tolerated3.77511-2.727.03
c.2186A>GN729S
(3D Viewer)
Likely BenignGAPUncertain 1-1.578Likely Benign0.066Likely BenignLikely Benign0.063Likely Benign0.14Likely Benign0.11.34Ambiguous0.74Ambiguous-0.36Likely Benign-0.42Neutral0.221Benign0.027Benign3.38Benign0.93Tolerated3.597112.7-27.03
c.3192G>CQ1064HLikely BenignUncertain 1-4.576Likely Benign0.162Likely BenignLikely Benign0.063Likely Benign-0.66Neutral0.938Possibly Damaging0.596Possibly Damaging4.15Benign0.05Affected300.39.01
c.2752G>AA918TLikely BenignUncertain 16-33443304-G-A16.20e-7-4.139Likely Benign0.083Likely BenignLikely Benign0.065Likely Benign-1.09Neutral0.980Probably Damaging0.721Possibly Damaging2.64Benign0.03Affected4.32401-2.530.03
c.502C>TH168YLikely BenignBenign 1-8.914Likely Pathogenic0.264Likely BenignLikely Benign0.065Likely Benign-1.53Neutral0.192Benign0.062Benign4.18Benign0.01Affected4.323021.926.03
c.2015C>AT672K
(3D Viewer)
Likely PathogenicGAPUncertain 1-12.192Likely Pathogenic0.698Likely PathogenicLikely Benign0.065Likely Benign0.20Likely Benign0.51.21Ambiguous0.71Ambiguous0.72Ambiguous-4.31Deleterious0.745Possibly Damaging0.051Benign3.40Benign0.07Tolerated3.40250-1-3.227.07195.17.00.40.70.40.1XXPotentially PathogenicThe hydroxyl group of Thr672, located in an entangled α-α loop connecting the two α-helices (res. Ser641-Glu666 and res. Leu685-Val699), is involved in a highly coordinated hydrogen-bonding network between residues from two α-helices (res. Ser641-Glu666 and res. Arg563-Glu578) and from the α-α loop itself, such as Lys566, Glu666, and Asn669. In the variant simulations, Lys672 can only form a hydrogen bond with the amino group of the Lys566 side chain via its backbone carbonyl group. Consequently, it cannot maintain the Lys566-Glu666 salt bridge through hydrogen bonding. However, the amino group of Lys periodically forms a salt bridge with the carboxylate group of Glu666, which prevents a drastic disruption of the hydrogen-bond network that keeps the loop close to the helices.
c.3449C>TA1150VLikely BenignUncertain 16-33444484-C-T31.86e-6-3.648Likely Benign0.192Likely BenignLikely Benign0.066Likely Benign-2.22Neutral0.114Benign0.055Benign2.32Pathogenic0.04Affected3.775002.428.05
c.2270G>CG757ALikely BenignUncertain 1-2.626Likely Benign0.091Likely BenignLikely Benign0.066Likely Benign-0.45Neutral0.267Benign0.127Benign2.73Benign0.35Tolerated102.214.03
c.526A>GS176GUncertain 16-33435168-A-G16.20e-7-7.541In-Between0.360AmbiguousLikely Benign0.066Likely Benign-1.08Neutral0.131Benign0.039Benign4.08Benign0.22Tolerated3.546010.4-30.03
c.2506A>GS836GLikely BenignUncertain 16-33443058-A-G42.48e-6-4.749Likely Benign0.112Likely BenignLikely Benign0.066Likely Benign-1.65Neutral0.006Benign0.019Benign2.54Benign0.39Tolerated3.775100.4-30.03
c.136C>TP46SLikely BenignUncertain 1-3.338Likely Benign0.302Likely BenignLikely Benign0.066Likely Benign-0.60Neutral0.909Possibly Damaging0.901Possibly Damaging4.15Benign0.00Affected1-10.8-10.04
c.3361A>GS1121GLikely BenignUncertain 16-33443913-A-G17.00e-7-1.220Likely Benign0.054Likely BenignLikely Benign0.067Likely Benign-0.53Neutral0.003Benign0.004Benign6.63Benign0.00Affected3.775010.4-30.03
c.3442A>TM1148LLikely BenignUncertain 1-1.777Likely Benign0.093Likely BenignLikely Benign0.068Likely Benign-1.13Neutral0.016Benign0.016Benign2.62Benign0.00Affected4.322421.9-18.03
c.2214T>GS738RLikely BenignBenign 16-33441679-T-G16.20e-7-4.241Likely Benign0.570Likely PathogenicLikely Benign0.068Likely Benign-1.55Neutral0.473Possibly Damaging0.193Benign2.69Benign0.01Affected4.3220-1-3.769.11
c.3194C>TP1065LLikely Benign 16-33443746-C-T148.71e-6-5.085Likely Benign0.089Likely BenignLikely Benign0.068Likely Benign-2.94Deleterious0.950Possibly Damaging0.419Benign2.01Pathogenic0.00Affected4.322-3-35.416.04
c.2924C>TT975ILikely BenignUncertain 16-33443476-C-T63.72e-6-3.912Likely Benign0.164Likely BenignLikely Benign0.068Likely Benign-1.66Neutral0.411Benign0.239Benign4.11Benign0.66Tolerated4.3220-15.212.05
c.2503C>AL835MLikely BenignBenign 1-4.153Likely Benign0.121Likely BenignLikely Benign0.068Likely Benign-0.45Neutral0.999Probably Damaging0.977Probably Damaging2.67Benign0.12Tolerated3.77524-1.918.03
c.3929C>TT1310MLikely BenignBenign 16-33451803-C-T171.05e-5-4.822Likely Benign0.117Likely BenignLikely Benign0.069Likely Benign2.19Neutral0.021Benign0.005Benign2.98Benign0.93Tolerated3.775-1-12.630.09
c.3913A>GT1305ALikely BenignConflicting 46-33451787-A-G301.86e-5-2.692Likely Benign0.055Likely BenignLikely Benign0.069Likely Benign1.74Neutral0.000Benign0.001Benign3.24Benign1.00Tolerated3.775102.5-30.03
c.70G>AV24ILikely BenignUncertain 16-33423479-G-A95.58e-6-3.701Likely Benign0.137Likely BenignLikely Benign0.069Likely Benign-0.25Neutral0.043Benign0.031Benign3.96Benign0.00Affected4.321340.314.03
c.286G>AG96SLikely BenignUncertain 16-33425894-G-A53.10e-6-3.049Likely Benign0.065Likely BenignLikely Benign0.071Likely Benign-0.76Neutral0.364Benign0.008Benign4.25Benign0.00Affected4.32110-0.430.03
c.2111G>CS704T
(3D Viewer)
Likely BenignGAPUncertain 1-4.930Likely Benign0.265Likely BenignLikely Benign0.071Likely Benign0.80Ambiguous0.00.15Likely Benign0.48Likely Benign0.29Likely Benign-1.72Neutral0.525Possibly Damaging0.107Benign3.45Benign0.07Tolerated3.4710110.114.03201.7-18.00.00.0-0.20.7XPotentially BenignSer704 is located at the end and outer surface of an α-helix (res. Thr704-Gly712), which is connected via a tight turn or loop to another α-helix (res. Asp684-Gln702). The hydroxyl side chain of Ser704 occasionally forms a hydrogen bond with the amide group of Ala707. Similarly, in the variant simulations, the hydroxyl side chain of Thr704 forms hydrogen bonds with the amide groups of Ala707 and Leu708. Thus, the residue swap does not cause any apparent structural change.
c.2215G>CE739QLikely BenignUncertain 1-2.846Likely Benign0.161Likely BenignLikely Benign0.071Likely Benign-1.06Neutral0.801Possibly Damaging0.339Benign2.57Benign0.00Affected4.322220.0-0.98
c.194A>GH65RLikely BenignUncertain 16-33425802-A-G16.20e-7-1.980Likely Benign0.967Likely PathogenicLikely Pathogenic0.073Likely Benign-1.60Neutral0.462Possibly Damaging0.227Benign4.19Benign0.00Affected4.32120-1.319.05
c.2493G>CE831DLikely BenignUncertain 16-33443045-G-C16.19e-7-3.055Likely Benign0.063Likely BenignLikely Benign0.073Likely Benign1.23Neutral0.002Benign0.002Benign2.64Benign0.77Tolerated3.775320.0-14.03
c.371C>TA124VLikely BenignConflicting 26-33432236-C-T95.58e-6-4.259Likely Benign0.138Likely BenignLikely Benign0.073Likely Benign-1.52Neutral0.173Benign0.009Benign4.07Benign0.03Affected3.615002.428.05
c.2914C>TP972SLikely BenignUncertain 16-33443466-C-T42.48e-6-4.008Likely Benign0.058Likely BenignLikely Benign0.074Likely Benign-0.38Neutral0.001Benign0.002Benign4.28Benign0.05Affected4.322-110.8-10.04
c.182A>CE61ALikely BenignUncertain 1-5.235Likely Benign0.453AmbiguousLikely Benign0.074Likely Benign-1.52Neutral0.458Possibly Damaging0.678Possibly Damaging4.12Benign0.00Affected0-15.3-58.04
c.2277G>AM759ILikely BenignUncertain 16-33441742-G-A16.20e-7-4.058Likely Benign0.393AmbiguousLikely Benign0.075Likely Benign-0.88Neutral0.454Possibly Damaging0.192Benign2.83Benign0.34Tolerated3.995122.6-18.03
c.2704G>AA902TLikely BenignLikely Benign 16-33443256-G-A362.23e-5-4.966Likely Benign0.116Likely BenignLikely Benign0.075Likely Benign-1.11Neutral0.951Possibly Damaging0.617Possibly Damaging2.61Benign0.01Affected3.77510-2.530.03
c.3020G>AS1007NLikely BenignBenign 1-5.113Likely Benign0.803Likely PathogenicAmbiguous0.075Likely Benign-1.54Neutral0.997Probably Damaging0.992Probably Damaging2.65Benign0.01Affected3.77511-2.727.03
c.382C>AP128TLikely BenignUncertain 16-33432247-C-A16.20e-7-4.217Likely Benign0.267Likely BenignLikely Benign0.075Likely Benign-0.96Neutral0.952Possibly Damaging0.500Possibly Damaging4.19Benign0.35Tolerated3.744-100.93.99
c.401G>AS134NLikely BenignUncertain 1-5.534Likely Benign0.813Likely PathogenicAmbiguous0.075Likely Benign-1.62Neutral0.001Benign0.002Benign3.90Benign0.00Affected3.61511-2.727.03
c.2195G>CR732TUncertain 1-8.545Likely Pathogenic0.434AmbiguousLikely Benign0.075Likely Benign-1.96Neutral0.999Probably Damaging0.892Possibly Damaging2.59Benign0.12Tolerated3.597-1-13.8-55.08
c.2381C>TP794LLikely BenignSH3-binding motifBenign/Likely benign 26-33442933-C-T734.52e-5-3.808Likely Benign0.079Likely BenignLikely Benign0.075Likely Benign-0.80Neutral0.761Possibly Damaging0.321Benign4.24Benign0.03Affected4.073-3-35.416.04
c.4013G>AR1338QLikely BenignConflicting 36-33451887-G-A128.40e-6-3.494Likely Benign0.317Likely BenignLikely Benign0.076Likely Benign-1.87Neutral0.896Possibly Damaging0.194Benign3.81Benign0.02Affected3.775111.0-28.06
c.3902C>GP1301RLikely BenignUncertain 16-33451776-C-G159.30e-6-4.753Likely Benign0.162Likely BenignLikely Benign0.076Likely Benign-1.13Neutral0.077Benign0.059Benign2.81Benign0.10Tolerated3.7750-2-2.959.07
c.227C>GS76CLikely BenignUncertain 16-33425835-C-G21.24e-6-5.408Likely Benign0.100Likely BenignLikely Benign0.076Likely Benign-1.78Neutral0.992Probably Damaging0.869Possibly Damaging3.71Benign0.00Affected4.3210-13.316.06
c.2221C>TP741SLikely BenignUncertain 26-33441686-C-T31.86e-6-3.700Likely Benign0.063Likely BenignLikely Benign0.076Likely Benign-0.27Neutral0.270Benign0.136Benign2.92Benign0.00Affected4.3221-10.8-10.0410.1016/j.ajhg.2020.11.011
c.3053C>TT1018IUncertain 16-33443605-C-T42.48e-6-3.264Likely Benign0.524AmbiguousLikely Benign0.076Likely Benign-2.55Deleterious0.586Possibly Damaging0.304Benign2.24Pathogenic0.01Affected3.775-105.212.05
c.256G>AV86ILikely BenignUncertain 1-4.726Likely Benign0.338Likely BenignLikely Benign0.076Likely Benign-0.31Neutral0.267Benign0.097Benign3.94Benign0.00Affected4.321430.314.03
c.218G>AR73KLikely BenignUncertain 16-33425826-G-A21.24e-6-4.033Likely Benign0.151Likely BenignLikely Benign0.077Likely Benign-0.46Neutral0.053Benign0.007Benign4.14Benign0.00Affected4.321230.6-28.01
c.187G>CE63QLikely BenignUncertain 1-4.038Likely Benign0.687Likely PathogenicLikely Benign0.078Likely Benign-0.85Neutral0.659Possibly Damaging0.775Possibly Damaging3.90Benign0.00Affected4.321220.0-0.98
c.2339C>GS780CLikely BenignUncertain 46-33442891-C-G169.94e-6-7.603In-Between0.278Likely BenignLikely Benign0.078Likely Benign-1.41Neutral0.065Benign0.043Benign2.59Benign0.10Tolerated3.646-103.316.06
c.3662G>AR1221QLikely BenignCoiled-coilConflicting 26-33446654-G-A42.48e-6-5.491Likely Benign0.115Likely BenignLikely Benign0.078Likely Benign-1.46Neutral0.836Possibly Damaging0.153Benign2.56Benign0.12Tolerated3.775111.0-28.06
c.2224C>TR742WLikely BenignUncertain 16-33441689-C-T63.72e-6-7.725In-Between0.133Likely BenignLikely Benign0.079Likely Benign-1.71Neutral0.992Probably Damaging0.684Possibly Damaging2.66Benign0.01Affected4.322-323.630.03
c.2116G>AE706K
(3D Viewer)
GAPUncertain 1-10.519Likely Pathogenic0.833Likely PathogenicAmbiguous0.080Likely Benign1.17Ambiguous0.10.51Ambiguous0.84Ambiguous0.08Likely Benign-1.51Neutral0.345Benign0.028Benign4.15Benign0.52Tolerated3.471001-0.4-0.94187.149.20.00.00.40.1XUncertainThe carboxylate side chain of Glu706, located at the end and outer surface of an α-helix (res. Thr704-Gly712), forms a salt bridge with Lys710 and a hydrogen bond with its own backbone amino group at the helix end in the WT simulations. Although Lys706 is unable to make these transient interactions in the variant simulations, there is no apparent negative effect on the protein structure due to the residue swap. However, because the model ends abruptly at the C-terminus, no definite conclusions can be drawn based on the simulations.
c.291G>TE97DLikely BenignUncertain 36-33425899-G-T-3.239Likely Benign0.077Likely BenignLikely Benign0.081Likely Benign-0.49Neutral0.880Possibly Damaging0.636Possibly Damaging4.12Benign0.00Affected4.321320.0-14.03
c.3305C>TA1102VLikely BenignBenign 16-33443857-C-T-2.440Likely Benign0.077Likely BenignLikely Benign0.081Likely Benign-1.27Neutral0.017Benign0.028Benign2.29Pathogenic0.12Tolerated3.775002.428.05
c.2888A>GH963RLikely BenignUncertain 16-33443440-A-G84.96e-6-8.952Likely Pathogenic0.169Likely BenignLikely Benign0.081Likely Benign-1.28Neutral0.001Benign0.003Benign4.15Benign0.24Tolerated3.77520-1.319.05
c.196C>TP66SLikely BenignBenign 16-33425804-C-T21.24e-6-2.760Likely Benign0.929Likely PathogenicAmbiguous0.081Likely Benign-1.69Neutral0.909Possibly Damaging0.641Possibly Damaging4.01Benign0.00Affected4.3211-10.8-10.04
c.88C>TH30YLikely BenignUncertain 1-3.047Likely Benign0.115Likely BenignLikely Benign0.082Likely Benign-1.84Neutral0.273Benign0.478Possibly Damaging3.99Benign0.00Affected4.321021.926.03
c.29G>AR10QLikely BenignUncertain 26-33420293-G-A201.30e-5-4.438Likely Benign0.185Likely BenignLikely Benign0.084Likely Benign0.03Neutral0.121Benign0.004Benign4.17Benign0.00Affected4.321111.0-28.06
c.2765G>AR922QLikely BenignBenign 16-33443317-G-A74.34e-6-3.295Likely Benign0.189Likely BenignLikely Benign0.085Likely Benign-0.27Neutral0.992Probably Damaging0.736Possibly Damaging2.57Benign0.20Tolerated3.775111.0-28.06
c.2932C>TP978SLikely BenignUncertain 1-3.913Likely Benign0.151Likely BenignLikely Benign0.085Likely Benign-1.07Neutral0.481Possibly Damaging0.220Benign4.22Benign0.48Tolerated1-10.8-10.04
c.163C>AQ55KLikely BenignUncertain 26-33423572-C-A241.49e-5-5.840Likely Benign0.612Likely PathogenicLikely Benign0.085Likely Benign-1.21Neutral0.140Benign0.184Benign3.91Benign0.00Affected4.32111-0.40.04
c.2989G>AA997TLikely BenignUncertain 1-4.102Likely Benign0.071Likely BenignLikely Benign0.085Likely Benign-0.62Neutral0.224Benign0.120Benign4.17Benign0.00Affected4.32410-2.530.03
c.2324G>AR775QLikely BenignConflicting 36-33442482-G-A111.41e-5-4.476Likely Benign0.229Likely BenignLikely Benign0.085Likely Benign-0.63Neutral0.969Probably Damaging0.863Possibly Damaging4.17Benign0.16Tolerated3.646111.0-28.0610.1016/j.ajhg.2020.11.011
c.2216A>TE739VLikely BenignUncertain 1-3.136Likely Benign0.274Likely BenignLikely Benign0.085Likely Benign-1.86Neutral0.891Possibly Damaging0.575Possibly Damaging2.47Pathogenic0.00Affected4.322-2-27.7-29.98
c.3092T>CM1031TLikely BenignUncertain 16-33443644-T-C21.24e-6-1.863Likely Benign0.540AmbiguousLikely Benign0.085Likely Benign-0.24Neutral0.002Benign0.005Benign2.67Benign1.00Tolerated3.775-1-1-2.6-30.09
c.43G>AA15TLikely BenignUncertain 16-33420307-G-A42.60e-6-3.720Likely Benign0.125Likely BenignLikely Benign0.086Likely Benign-0.08Neutral0.602Possibly Damaging0.017Benign4.16Benign0.00Affected4.32110-2.530.03
c.2998A>GI1000VLikely BenignUncertain 2-4.102Likely Benign0.098Likely BenignLikely Benign0.086Likely Benign-0.20Neutral0.437Benign0.170Benign2.76Benign0.81Tolerated4.32434-0.3-14.03
c.2858C>AP953QLikely BenignUncertain 1-6.038Likely Benign0.079Likely BenignLikely Benign0.086Likely Benign-0.78Neutral0.058Benign0.015Benign2.78Benign0.29Tolerated3.7750-1-1.931.01
c.404G>AR135QUncertain 16-33432701-G-A53.84e-6-8.011Likely Pathogenic0.853Likely PathogenicAmbiguous0.087Likely Benign-1.94Neutral0.327Benign0.100Benign3.76Benign0.02Affected3.615111.0-28.06
c.3103C>AP1035TLikely BenignUncertain 1-4.447Likely Benign0.426AmbiguousLikely Benign0.087Likely Benign-0.96Neutral0.901Possibly Damaging0.537Possibly Damaging2.72Benign0.23Tolerated3.7750-10.93.99
c.155C>TS52LUncertain 16-33423564-C-T16.20e-7-7.199In-Between0.688Likely PathogenicLikely Benign0.087Likely Benign-1.41Neutral0.829Possibly Damaging0.706Possibly Damaging4.10Benign0.00Affected4.321-3-24.626.08
c.2954G>AS985NLikely BenignUncertain 1-6.979Likely Benign0.845Likely PathogenicAmbiguous0.088Likely Benign-1.68Neutral0.991Probably Damaging0.988Probably Damaging2.65Benign0.00Affected4.32111-2.727.03
c.1918A>TT640S
(3D Viewer)
Likely BenignGAPBenign 16-33441177-A-T16.20e-7-2.371Likely Benign0.062Likely BenignLikely Benign0.088Likely Benign-0.78Ambiguous0.10.43Likely Benign-0.18Likely Benign-0.30Likely Benign0.92Neutral0.000Benign0.001Benign3.60Benign0.33Tolerated3.373011-0.1-14.03
c.3310C>TP1104SLikely BenignBenign 16-33443862-C-T16.54e-7-2.330Likely Benign0.073Likely BenignLikely Benign0.088Likely Benign-0.30Neutral0.770Possibly Damaging0.404Benign2.77Benign0.10Tolerated3.775-110.8-10.04
c.2632A>GT878ALikely BenignUncertain 1-2.154Likely Benign0.081Likely BenignLikely Benign0.088Likely Benign-0.67Neutral0.003Benign0.006Benign2.73Benign0.18Tolerated3.775102.5-30.03
c.3964G>CA1322PLikely BenignBenign 16-33451838-G-C-1.153Likely Benign0.063Likely BenignLikely Benign0.090Likely Benign0.03Neutral0.000Benign0.000Benign4.15Benign0.23Tolerated3.7751-1-3.426.04
c.2557G>CG853RLikely BenignUncertain 1-4.749Likely Benign0.366AmbiguousLikely Benign0.091Likely Benign-1.27Neutral0.846Possibly Damaging0.624Possibly Damaging4.18Benign0.00Affected-3-2-4.199.14
c.196C>GP66ALikely BenignUncertain 1-2.845Likely Benign0.891Likely PathogenicAmbiguous0.091Likely Benign-1.56Neutral0.805Possibly Damaging0.539Possibly Damaging4.04Benign0.00Affected4.3211-13.4-26.04
c.819G>TE273D
(3D Viewer)
Likely BenignC2Benign 16-33437724-G-T21.24e-6-1.811Likely Benign0.058Likely BenignLikely Benign0.092Likely Benign0.26Likely Benign0.1-0.48Likely Benign-0.11Likely Benign-0.63Ambiguous1.99Neutral0.004Benign0.010Benign2.00Pathogenic1.00Tolerated3.3818320.0-14.03223.122.10.20.00.00.1XPotentially BenignThe negatively charged residue Glu273, located in a β hairpin loop (res. Glu273-Lys278) that connects two anti-parallel β sheet strands, is replaced with another negatively charged residue, aspartate. Because the C2 domain loop faces the membrane surface, the potentially crucial role of the carboxylate group of Glu273 or Asp273 on SynGAP-membrane association cannot be fully explored via solvent-only simulations.As a minor note, the neighboring residue Arg272, which stacks with the indole ring of the Trp362 side chain and directly faces RasGTPase, forms a salt bridge more often with Asp273 than with the non-mutated Glu273 in the simulations. Regardless, due to the similar physicochemical properties of the WT and variant residues at the membrane interface, the residue swap is likely to be well tolerated.
c.3949G>AG1317SLikely BenignConflicting 36-33451823-G-A16.26e-7-3.522Likely Benign0.145Likely BenignLikely Benign0.092Likely Benign-2.45Neutral0.127Benign0.045Benign4.08Benign0.00Affected3.77510-0.430.03
c.2362T>AS788TLikely BenignSH3-binding motifUncertain 26-33442914-T-A42.49e-6-4.288Likely Benign0.288Likely BenignLikely Benign0.092Likely Benign-2.25Neutral0.979Probably Damaging0.982Probably Damaging1.55Pathogenic0.02Affected3.646110.114.03
c.5G>AS2NLikely BenignUncertain 26-33420269-G-A31.96e-6-4.104Likely Benign0.207Likely BenignLikely Benign0.092Likely Benign-0.36Neutral0.000Benign0.000Benign4.06Benign0.00Affected4.32111-2.727.03
c.3979C>TP1327SLikely BenignUncertain 16-33451853-C-T-4.744Likely Benign0.131Likely BenignLikely Benign0.092Likely Benign0.28Neutral0.980Probably Damaging0.857Possibly Damaging4.25Benign0.71Tolerated3.7751-10.8-10.04
c.280C>TP94SLikely BenignBenign 16-33425888-C-T53.10e-6-3.151Likely Benign0.084Likely BenignLikely Benign0.093Likely Benign-2.36Neutral0.092Benign0.008Benign4.13Benign0.00Affected4.3211-10.8-10.04
c.2864C>TS955FConflicting 46-33443416-C-T955.89e-5-7.374In-Between0.176Likely BenignLikely Benign0.093Likely Benign-1.73Neutral0.977Probably Damaging0.721Possibly Damaging2.32Pathogenic0.00Affected3.775-3-23.660.10
c.121C>TR41CLikely BenignConflicting 36-33423530-C-T74.34e-6-4.745Likely Benign0.207Likely BenignLikely Benign0.093Likely Benign-1.10Neutral0.976Probably Damaging0.919Probably Damaging4.13Benign0.00Affected4.321-4-37.0-53.05
c.277C>GR93GLikely BenignUncertain 1-2.674Likely Benign0.400AmbiguousLikely Benign0.093Likely Benign-1.69Neutral0.103Benign0.019Benign3.99Benign0.00Affected4.321-2-34.1-99.14
c.3638A>GN1213SLikely BenignCoiled-coilBenign 16-33446630-A-G138.05e-6-4.086Likely Benign0.081Likely BenignLikely Benign0.094Likely Benign-0.56Neutral0.906Possibly Damaging0.551Possibly Damaging2.82Benign0.68Tolerated3.775112.7-27.0310.1016/j.ajhg.2020.11.011
c.249A>TR83SLikely BenignUncertain 1-2.550Likely Benign0.999Likely PathogenicLikely Pathogenic0.094Likely Benign-1.87Neutral0.909Possibly Damaging0.587Possibly Damaging3.19Benign0.00Affected4.3210-13.7-69.11
c.2294G>AS765NLikely BenignUncertain 1-5.098Likely Benign0.378AmbiguousLikely Benign0.094Likely Benign-0.94Neutral0.985Probably Damaging0.950Probably Damaging4.11Benign0.06Tolerated3.64611-2.727.03
c.600G>CL200F
(3D Viewer)
PHUncertain 16-33435242-G-C21.24e-6-7.606In-Between0.592Likely PathogenicLikely Benign0.094Likely Benign1.00Ambiguous0.51.45Ambiguous1.23Ambiguous0.43Likely Benign-1.97Neutral0.997Probably Damaging0.916Probably Damaging4.02Benign0.17Tolerated3.46920-1.034.02250.4-15.10.60.20.50.0XUncertainLeu200, a hydrophobic residue located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by another hydrophobic residue, phenylalanine. Both the phenyl group of Phe200 and the branched iso-butyl hydrocarbon sidechain of Leu200 occupy an inward hydrophobic niche (e.g., Leu246, Val222, Phe231) during the simulations. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.265C>GP89ALikely BenignUncertain 2-5.778Likely Benign0.920Likely PathogenicAmbiguous0.095Likely Benign-2.47Neutral0.225Benign0.020Benign3.77Benign0.00Affected4.3211-13.4-26.04
c.314C>TS105LLikely BenignUncertain 26-33432179-C-T42.48e-6-3.710Likely Benign0.233Likely BenignLikely Benign0.095Likely Benign-1.52Neutral0.828Possibly Damaging0.048Benign4.06Benign0.00Affected4.321-3-24.626.08
c.2299A>GI767VLikely BenignUncertain 1-2.791Likely Benign0.064Likely BenignLikely Benign0.096Likely Benign0.10Neutral0.072Benign0.029Benign4.21Benign1.00Tolerated3.64643-0.3-14.03
c.958G>CV320L
(3D Viewer)
C2Uncertain 16-33437863-G-C63.72e-6-6.207Likely Benign0.362AmbiguousLikely Benign0.096Likely Benign-0.26Likely Benign0.21.33Ambiguous0.54Ambiguous0.51Ambiguous-1.02Neutral0.900Possibly Damaging0.373Benign1.78Pathogenic0.92Tolerated3.382321-0.414.03245.8-10.20.30.90.10.3XPotentially BenignThe isopropyl side chain of Val310, located in a β hairpin loop linking two anti-parallel β sheet strands (res. Thr305-Asn315, res. Ala322-Asp330), hydrophobically packs with the side chains of nearby residues (e.g., Leu286, Val350, Pro318). The hydrophobic Leu320 side chain mostly forms the same interactions; hence, the residue swap does not seem to negatively affect the protein structure based on the variant simulations.
c.140G>AR47QLikely BenignLikely Benign 16-33423549-G-A42.48e-6-4.989Likely Benign0.347AmbiguousLikely Benign0.096Likely Benign-0.57Neutral0.829Possibly Damaging0.614Possibly Damaging4.12Benign0.00Affected4.321111.0-28.0610.1016/j.ajhg.2020.11.011
c.3638A>CN1213TLikely BenignCoiled-coilConflicting 26-33446630-A-C462.85e-5-5.428Likely Benign0.266Likely BenignLikely Benign0.097Likely Benign-1.08Neutral0.959Probably Damaging0.721Possibly Damaging2.74Benign1.00Tolerated3.775002.8-13.00
c.3958C>TP1320SLikely BenignUncertain 16-33451832-C-T21.28e-6-4.928Likely Benign0.073Likely BenignLikely Benign0.097Likely Benign-0.69Neutral0.980Probably Damaging0.968Probably Damaging4.25Benign0.00Affected3.7751-10.8-10.04
c.2217G>CE739DLikely BenignUncertain 1-3.369Likely Benign0.062Likely BenignLikely Benign0.097Likely Benign-0.49Neutral0.002Benign0.005Benign2.59Benign0.00Affected320.0-14.03
c.36C>GS12RLikely BenignUncertain 16-33420300-C-G42.59e-6-4.033Likely Benign0.500AmbiguousLikely Benign0.097Likely Benign-0.30Neutral0.000Benign0.000Benign4.09Benign0.00Affected4.3210-1-3.769.11
c.2514C>AN838KLikely PathogenicUncertain 2-8.470Likely Pathogenic0.862Likely PathogenicAmbiguous0.097Likely Benign-2.78Deleterious0.997Probably Damaging0.995Probably Damaging2.69Benign0.16Tolerated3.77510-0.414.07
c.2863T>CS955PLikely BenignUncertain 16-33443415-T-C31.86e-6-2.584Likely Benign0.073Likely BenignLikely Benign0.098Likely Benign-0.75Neutral0.001Benign0.004Benign2.33Pathogenic0.00Affected3.7751-1-0.810.04
c.4021G>TA1341SLikely BenignUncertain 16-33451895-G-T-2.867Likely Benign0.078Likely BenignLikely Benign0.099Likely Benign0.80Neutral0.000Benign0.001Benign4.40Benign1.00Tolerated3.77511-2.616.00
c.391G>CG131RUncertain 1-6.564Likely Benign0.983Likely PathogenicLikely Pathogenic0.099Likely Benign-3.82Deleterious0.983Probably Damaging0.656Possibly Damaging3.92Benign0.00Affected3.615-2-3-4.199.14
c.4021G>AA1341TLikely BenignConflicting 36-33451895-G-A453.44e-5-3.224Likely Benign0.081Likely BenignLikely Benign0.099Likely Benign-0.58Neutral0.000Benign0.000Benign4.09Benign0.03Affected3.77510-2.530.03
c.59C>TP20LLikely BenignUncertain 3-3.289Likely Benign0.464AmbiguousLikely Benign0.100Likely Benign-0.44Neutral0.909Possibly Damaging0.713Possibly Damaging4.27Benign0.00Affected4.321-3-35.416.04
c.3344T>CI1115TLikely BenignBenign 96-33443896-T-C205361.36e-2-2.670Likely Benign0.068Likely BenignLikely Benign0.100Likely Benign-0.04Neutral0.000Benign0.001Benign2.76Benign0.23Tolerated4.3220-1-5.2-12.05
c.2924C>AT975NLikely BenignUncertain 16-33443476-C-A16.20e-7-4.671Likely Benign0.089Likely BenignLikely Benign0.100Likely Benign-0.58Neutral0.586Possibly Damaging0.302Benign4.13Benign0.07Tolerated4.32200-2.813.00
c.68A>GD23GLikely BenignUncertain 1-2.622Likely Benign0.684Likely PathogenicLikely Benign0.100Likely Benign-2.45Neutral0.805Possibly Damaging0.539Possibly Damaging3.50Benign0.00Affected1-13.1-58.04
c.2343G>AM781ILikely BenignBenign 1-2.484Likely Benign0.323Likely BenignLikely Benign0.101Likely Benign0.05Neutral0.000Benign0.001Benign2.89Benign1.00Tolerated3.646122.6-18.03
c.2219G>AR740QLikely BenignUncertain 16-33441684-G-A42.48e-6-5.195Likely Benign0.078Likely BenignLikely Benign0.102Likely Benign-0.67Neutral0.999Probably Damaging0.881Possibly Damaging2.60Benign0.08Tolerated4.322111.0-28.06
c.304T>GL102VLikely BenignUncertain 16-33432169-T-G16.20e-7-4.316Likely Benign0.068Likely BenignLikely Benign0.102Likely Benign0.32Neutral0.880Possibly Damaging0.899Possibly Damaging4.21Benign0.00Affected4.321210.4-14.03
c.53A>GY18CLikely BenignUncertain 16-33420317-A-G442.88e-5-2.658Likely Benign0.251Likely BenignLikely Benign0.102Likely Benign-0.56Neutral0.872Possibly Damaging0.206Benign4.04Benign0.00Affected4.3210-23.8-60.04
c.2971G>AG991RLikely BenignConflicting 36-33443523-G-A84.96e-6-3.934Likely Benign0.411AmbiguousLikely Benign0.102Likely Benign-1.20Neutral0.984Probably Damaging0.772Possibly Damaging4.11Benign0.01Affected4.322-3-2-4.199.14
c.2881C>TH961YLikely BenignConflicting 26-33443433-C-T31.86e-6-8.051Likely Pathogenic0.157Likely BenignLikely Benign0.102Likely Benign-1.07Neutral0.716Possibly Damaging0.147Benign4.10Benign0.55Tolerated3.775021.926.03
c.187G>AE63KLikely BenignUncertain 1-4.976Likely Benign0.894Likely PathogenicAmbiguous0.103Likely Benign-0.70Neutral0.458Possibly Damaging0.678Possibly Damaging3.98Benign0.00Affected4.32110-0.4-0.94
c.3238G>TA1080SLikely BenignUncertain 16-33443790-G-T16.26e-7-3.277Likely Benign0.108Likely BenignLikely Benign0.103Likely Benign0.01Neutral0.702Possibly Damaging0.346Benign4.16Benign0.08Tolerated3.77511-2.616.00
c.3824G>AR1275QLikely BenignUncertain 16-33447872-G-A21.29e-6-4.928Likely Benign0.121Likely BenignLikely Benign0.103Likely Benign-1.72Neutral0.898Possibly Damaging0.147Benign2.59Benign0.03Affected3.775111.0-28.06

Found 757 rows. Show 200 rows per page. Page 1/4 |